AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01

Amgen, Inc.

recall status: Terminated 06/02/2017

11,434 vials distributed United States and Puerto Rico No foreign distribution.

Lack of Assurance of Sterility: Potential cracks in glass vials

Voluntary: Firm Initiated